Log In
BCIQ
Print this Print this
 

iboctadekin (485232) (SB-485232)

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionRecombinant interleukin-18 (IL-18)
Molecular Target Interleukin-18 (IL-18)
Mechanism of ActionImmune modulation
Therapeutic ModalityBiologic: Protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today